Purine derivatives useful as HSP90 inhibitors

Details for Australian Patent Application No. 2010303343 (hide)

Owner Sloan-Kettering Institute for Cancer Research

Inventors Chiosis, Gabriela; Taldone, Tony; Sun, Weilin

Agent Debra Tulloch

Pub. Number AU-A-2010303343

PCT Pub. Number WO2011/044394

Priority 61/249,349 07.10.09 US

Filing date 7 October 2010

Wipo publication date 14 April 2011

International Classifications

C07D 473/34 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61K 31/538 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/044394 Priority application(s): WO2011/044394

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010303354-Wheelchair suspension

2010303324-Apogossypolone derivatives as anticancer agents